Related Experiment Video

Updated: Nov 30, 2025

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

548

ADIPS 2020 guideline for pre-existing diabetes and pregnancy

Victoria L Rudland1,2, Sarah A L Price3,4,5,6, Ruth Hughes7

  • 1Department of Diabetes and Endocrinology, Westmead Hospital, Sydney, New South Wales, Australia.

The Australian & New Zealand Journal of Obstetrics & Gynaecology
|November 17, 2020
PubMed

Insights

This guideline provides comprehensive management strategies for pre-existing diabetes in pregnancy. It covers preconception, pregnancy, and postpartum care for type 1, type 2, monogenic, and cystic fibrosis-related diabetes.

Area of Science:

  • Obstetrics and Gynecology
  • Endocrinology
  • Reproductive Medicine

Background:

  • Pre-existing diabetes significantly impacts pregnancy outcomes.
  • Comprehensive guidelines are essential for optimal maternal and fetal health.
  • Management requires a multidisciplinary approach throughout the pregnancy continuum.

Purpose of the Study:

  • To present the full Australasian Diabetes in Pregnancy Society (ADIPS) 2020 guideline.
  • To provide evidence-based recommendations for managing pre-existing diabetes in pregnancy.
  • To address preconception, antepartum, intrapartum, and postpartum care.

Main Methods:

  • Consensus-based guideline development.
  • Systematic review of existing literature.
  • Expert opinion and clinical experience integration.

Main Results:

  • Detailed recommendations for glycemic control in type 1 and type 2 diabetes.
  • Specific considerations for monogenic and cystic fibrosis-related diabetes.
  • Guidance on fetal surveillance and delivery timing.

Conclusions:

  • Adherence to the ADIPS 2020 guideline improves pregnancy outcomes for women with pre-existing diabetes.
  • Integrated care is crucial for managing complex cases.
  • The guideline serves as a vital resource for healthcare professionals.

Keywords:
AustraliaNew Zealanddiabetes mellitushigh-risk pregnancypostnatal carepractice guidelinepreconception carepregnancytype 1 diabetestype 2 diabetes

More Related Videos

Author Spotlight: Enhancing the Offspring Health in Rats with Maternal Exercise During Pregnancy05:17

Author Spotlight: Enhancing the Offspring Health in Rats with Maternal Exercise During Pregnancy

Published on: April 5, 2024

1.1K
Multidisciplinary Approach to Obesity Management: A Case Report05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

673

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.9K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.6K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.7K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.5K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
740
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
481